EN
HI
Summary
As of 30 Oct, 2026, Gland Pharma stock price is ₹3095.9. During the trading session, the stock has moved between an intraday low of ₹3051.00 and an intraday high of ₹3114.20. Over the last 52 weeks, Gland Pharma has traded between ₹1573.60 and ₹3171.00.
The stock has recorded a trading volume of 3,00,302 shares,. Its Average Traded Price (ATP) is ₹3093.27, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 45 @ ₹3095.90.
Gland Pharma has an upper circuit limit of ₹3689.40 and a lower circuit limit of ₹2459.60. The total value traded stands at ₹92.89 CR, and the delivery percentage for the day is 68.53%.
The stock is currently traded with a market lot size of 1. Gland Pharma also offers a dividend yield of 0.65%.
Gland Pharma Share Price Chart
Gland Pharma Share Key Metrics
Volume
3.00 L
Market Cap
51085.71 CR
LTQ@LTP
45@3095.90
ATP
3093.27
Var Margin
17.01 %
Circuit Range
2459.6-3689.4
Delivery %
68.53 %
Value
92.89 CR
ASM/GSM
No
Market Lot
1
Gland Pharma Fundamentals
P/E Ratio
44.95
P/B Ratio
4.77
Div. Yield
0.65
Sector P/E
39.93
Sector P/B
3.3
Sec. Div. Yield
0.53
Gland Pharma Resistance and Support
Pivot 3065.57
Resistance
First Resistance
3120.14
Second Resistance
3165.77
Third Resistance
3220.34
Support
First Support
3019.94
Second Support
2965.37
Third Support
2919.74
Gland Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 30 2026 | 3070 | 3095.9 | 0.70% | 3114.2 | 3051 |
| Thu Oct 29 2026 | 3060 | 3074.5 | 0.84% | 3111.19 | 3011 |
| Wed Oct 28 2026 | 2950 | 3049 | 3.00% | 3061.5 | 2924 |
Gland Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-06 | Quarterly Results |
| 2026-08-10 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-08-05 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-11-04 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
Gland Pharma News
Gland Pharma Ltd - 543245 - Conclusion Of USFDA Unannounced Inspection At Company''s Formulation Facility At Dundigal, Hyderabad
Gland Pharma concluded an unannounced USFDA inspection at its Dundigal formulation facility with four Form 483 observations. The company confirmed that the observations are procedural in nature and do not relate to data integrity.
Oct 23 2026 16:21:50
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Gland Pharma approved a USD 21 million investment through its wholly-owned US subsidiary to acquire a 60% stake in Novelstar Pharma Inc. The newly incorporated target, co-owned 40% by Fosun Pharma USA, will help facilitate the company's strategic expansion in the United States.
Oct 01 2026 15:51:40
Read More
Gland Pharma Management
| Name | Position |
|---|---|
| Sampath Kumar Pallerlamudi | Company Secretary & Compliance Officer |
| Srinivas Sadu | Chairman |
Gland Pharma Similar Stocks
Aster DM Quality Care Ltd.
681.15
1.95 (0.29%)
Fortis Healthcare Ltd.
768.15
13.25 (1.76%)
Biocon Ltd.
351.80
-0.10 (0.03%)
Abbott India Ltd.
25635.00
-510.00 (1.95%)
Ipca Laboratories Ltd.
1927.80
1.60 (0.08%)
Anthem Biosciences Ltd.
828.80
-1.35 (0.16%)
Ajanta Pharma Ltd.
3508.80
49.10 (1.42%)
Glaxosmithkline Pharmaceuticals Ltd.
2494.30
-20.80 (0.83%)
Gland Pharma FAQs
The Buying Price of Gland Pharma share is 3095.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gland Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gland Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gland Pharma shares is 44.95. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gland Pharma shares is 4.77. Useful to assess the stock's value relative to its book value.
To assess Gland Pharma’s valuation compare Sector P/E, P/B which are 39.93 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gland Pharma is 51085.71 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gland Pharma share price is 3171.00 & 1573.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gland Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLAND
